Patent · US Active

Methods for partner agnostic gene fusion detection

US12139753B2 · kind B2 · utility

0Cited by
0References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2020
Grant dateNov 12, 2024
Priority date
Expiry dateMay 28, 2043

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG16B30/00
  • WIPO fieldComputer technology
  • WIPO sectorElectrical engineering

Abstract

A method for detecting a gene fusion includes amplifying a nucleic acid sample in the presence of primer pool to produce a plurality of amplicons. The primer pool includes primers targeting a plurality of exon-exon junctions of a driver gene. The amplicons correspond to the exon-exon junctions. The amplicons are sequenced and aligned to a reference sequence. The number of reads corresponding to each amplicon is normalized to give a normalized read count. A baseline correction is applied to the normalized read counts for the amplicons to form corrected read counts. A binary segmentation score is calculated for each corrected read count. A predicted breakpoint for the gene fusion is determined based on the amplicon index corresponding to the maximum absolute binary segmentation score. Gene fusion events may be detected in a partner agnostic manner, i.e. without prior knowledge of the specific fusion partner genes or specific breakpoint information.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.